Centiva Capital’s Picard Medical PMI Stock Holding History

Centiva Capital’s Portfolio PMI Stock Details PMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-848	Closed	-$361K	–	1700
2025 Q3	$361K	Buy	+848	New	+$299K	﹤0.01%	723

Other funds holding PMI

Aristides Capital Louisville, Kentucky $514M AUM 29.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WMP

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Centiva Capital's PMI Position: Q4 2025 in Review

Centiva Capital sold out of Picard Medical (PMI) in Q4 2025, closing a stake of 848 shares — an estimated $361K sold.

Centiva Capital first reported a position in PMI in Q3 2025 and held it in 1 quarter. The position peaked at $361K in Q3 2025. 31 funds tracked by Wall St. Rank hold PMI as of Q4 2025.

Centiva Capital reported no remaining Picard Medical position as of Q4 2025 after selling out during the quarter.
Centiva Capital sold 848 Picard Medical shares in Q4 2025, an estimated $361K.
Centiva Capital first reported a position in Picard Medical in Q3 2025 and held it in 1 quarter.
Centiva Capital's Picard Medical position peaked at $361K in Q3 2025.
31 funds tracked by Wall St. Rank held Picard Medical as of Q4 2025.

Based on Centiva Capital's 13F filing for Q4 2025, filed 13 Feb 2026.